To confirm the functional role of Itgβ1 upon EMT with human NSCLC cells, we treated H157 cells with the Itgβ1-blocking antibody either from day 0 or day 7, when the cells were starting to form protrusive structures in Matrigel-collagen I cultures. Here, ITGB1 is linked to non-small cell lung carcinoma.